Axon Capital’s Momentus MNTS Stock Holding History

Axon Capital’s Portfolio MNTS Stock Details MNTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18	Closed	-$718K	–	10
2022 Q1	$718K	Sell	18 -14	-44%	-$540K	1.67%	7
2021 Q4	$1.69M	Buy	+32	New	+$3.39M	2.71%	7

Other funds holding MNTS

PML

Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Axon Capital's MNTS Position: Q2 2022 in Review

Axon Capital sold out of Momentus (MNTS) in Q2 2022, closing a stake of 18 shares — an estimated $718K sold.

Axon Capital first reported a position in MNTS in Q4 2021 and held it in 2 quarters. The position peaked at $1.69M in Q4 2021. 60 funds tracked by Wall St. Rank hold MNTS as of Q2 2022.

Axon Capital reported no remaining Momentus position as of Q2 2022 after selling out during the quarter.
Axon Capital sold 18 Momentus shares in Q2 2022, an estimated $718K.
Axon Capital first reported a position in Momentus in Q4 2021 and held it in 2 quarters.
Axon Capital's Momentus position peaked at $1.69M in Q4 2021.
60 funds tracked by Wall St. Rank held Momentus as of Q2 2022.

Based on Axon Capital's 13F filing for Q2 2022, filed 10 Aug 2022.